Kopp Investment Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$3.97M Sell
207,781
-119,657
-37% -$2.81M 7.3% 1
2019
Q2
$7.18M Sell
327,438
-68,889
-17% -$1.51M 8.18% 1
2019
Q1
$8.11M Sell
396,327
-17,280
-4% -$300K 6.56% 2
2018
Q4
$5.22M Sell
413,607
-1,226
-0.3% -$18.3K 5.09% 4
2018
Q3
$6.37M Sell
414,833
-22,139
-5% -$306K 5.36% 1
2018
Q2
$5.73M Buy
436,972
+39,495
+10% +$435K 5.37% 2
2018
Q1
$3.24M Sell
397,477
-8,967
-2% -$72.6K 3.3% 8
2017
Q4
$3.6M Sell
406,444
-47,904
-11% -$442K 3.61% 6
2017
Q3
$5.06M Sell
454,348
-6,454
-1% -$62.8K 4.63% 4
2017
Q2
$4.13M Sell
460,802
-34,080
-7% -$270K 3.7% 6
2017
Q1
$3.9M Buy
494,882
+10,100
+2% +$82.3K 3.82% 6
2016
Q4
$4.16M Sell
484,782
-14,800
-3% -$127K 4.39% 5
2016
Q3
$4.11M Sell
499,582
-977,320
-66% -$8.2M 4.06% 5
2016
Q2
$11.9M Buy
1,476,902
+48,354
+3% +$388K 6.32% 3
2016
Q1
$9.63M Sell
1,428,548
-138,978
-9% -$915K 5.25% 3
2015
Q4
$12.3M Buy
1,567,526
+4,258
+0.3% +$31.2K 6.06% 5
2015
Q3
$8.96M Sell
1,563,268
-400,930
-20% -$2.48M 4.82% 7
2015
Q2
$10.6M Buy
1,964,198
+223,135
+13% +$1.15M 4.73% 7
2015
Q1
$8.13M Buy
1,741,063
+148,231
+9% +$644K 3.6% 6
2014
Q4
$6.64M Sell
1,592,832
-18,300
-1% -$84.1K 3.19% 9
2014
Q3
$8.39M Buy
1,611,132
+1,102,215
+217% +$5.66M 4.15% 6
2014
Q2
$1.69M Buy
508,917
+173,540
+52% +$577K 0.78% 30
2014
Q1
$1.16M Buy
335,377
+183,320
+121% +$687K 0.49% 34
2013
Q4
$550K Sell
152,057
-587,438
-79% -$2.04M 0.25% 55
2013
Q3
$2.22M Buy
739,495
+144,920
+24% +$408K 0.82% 28
2013
Q2
$2.37M Buy
+594,575
New +$2.27M 0.92% 25

Other funds holding NEO

Kopp Investment Advisors's NEO Position: Q3 2019 in Review

Kopp Investment Advisors reduced its NeoGenomics (NEO) stake by 37% in Q3 2019, selling an estimated $2.81M and leaving 207,781 shares worth $3.97M. The position accounts for 7.3% of the portfolio, ranked #1.

Kopp Investment Advisors first reported a position in NEO in Q2 2013 and has held it in 26 quarters since. The position peaked at $12.3M in Q4 2015. 253 funds tracked by Wall St. Rank hold NEO as of Q3 2019.

  • Kopp Investment Advisors held 207,781 shares of NeoGenomics worth $3.97M as of Q3 2019.
  • Kopp Investment Advisors sold 119,657 NeoGenomics shares in Q3 2019, an estimated $2.81M.
  • NeoGenomics made up 7.3% of Kopp Investment Advisors's portfolio in Q3 2019, its #1 holding.
  • Kopp Investment Advisors first reported a position in NeoGenomics in Q2 2013 and has held it in 26 quarters since.
  • Kopp Investment Advisors's NeoGenomics position peaked at $12.3M in Q4 2015.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2019.

Based on Kopp Investment Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.